Description
Formulated with exclusive QUADRAplumpTM extracts, and a concentrated micodelivery vitamin cocktail, the nutrient rich formula of Boustise Breast Enhancement Cream, 2.7 oz, helps to achieve a more full, renewed, and visibly lifted bustline, butt without costly and invasive procedures… all within weeks! Boustise is able to provide fast acting results with QUADRAplump, a unique blend of four intense, fat trapping, moisture capturing organic supercritical Co2 extracted actives in for enhanced absorbtion without any solvent byproducts or fillers. Our all natural breast enhancement formula also consists of multi-peptides, antioxidants, and vitamins, including niacin, CoQ10, and skin regenerative fat soluble microdelivery forms of vitamin A, C, and E. Boustise provides noticible breast enlargement, lift, firming and skin rejuvenation in as little as 4 to 6 weeks with twice daily use. Results continue into the second and third month with extended use. Fat cells are reported to duplicate in number once they reached their fill capacity for a period of time, providing long lasting results after discontinuation. This has been reported with application into 6 months done at least 2 to 3 times per week. Women looking for natural breast plumping and firming without the use of surgery can attain plumped perfection with the potent fast acting formula of Boustise Bust Plumping Lotion!
Contains QuadraplumpTM with 4 Potent Plant Based Fat Trapping Moisture Binding Bust Enlargement Actives
Average 1 Cup Size of Increased Bust Volume, and Increased Firmness Observed After 6-8 weeks. Some Users Reported Additional Increase Into 3rd Month.
Breast cream with Collagen Supporting Multipeptides and a Potent Microdelivery Vitamin Cocktail for Dramatic Skin Strengthening and Lift
Lightweight Professional Grade Breast Enhancement Serum. Unlike breast pills, specifically targeted application to enlarge breasts or butt (Made in Canada)
Paraben free* Bust Plumping Serum Cream Using Organic Lab Grade CO2 extracts
Reviews
There are no reviews yet.